Stock listing

TSXV:VXL Vaxil Bio Ltd. Stock

Home listing (TSXV) of Vaxil Bio Ltd.

Follow Vaxil Bio Ltd. into a list and get an email when it puts out news.

Share price · TSXV:VXL

$0.115 CAD 0.000 (0.0%)

Close on Nov 19, 2026

Past year -23.3% · daily closes, Nov 19, 2025 – Nov 19, 2026, adjusted for splits
Day range
$0.115 – $0.115 CADNov 19, 2026
Market cap
$458,162 CADAt the close on Nov 19, 2026 · price × 3.98M shares outstanding
52-week range
$0.100 – $0.290 CADLowest and highest trades, Nov 20, 2025 – Nov 19, 2026
Traded on an average day
$210 CADMedian day 0 shares · 43 days with no trades · last 3 months, Aug 19, 2026 – Nov 19, 2026
Vaxil Bio Ltd. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
TSXV:VXL · Home$0.115 CAD0.000 (0.0%)—$0.115$0.115$0.115$0.115Close on Nov 19, 2026

Daily closes

Last 3 months, Aug 19, 2026 – Nov 19, 2026 · TSXV:VXL · CAD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.1150.0000.0%$0.115$0.115$0.1150
$0.1150.0000.0%$0.115$0.115$0.1150
$0.1150.0000.0%$0.115$0.115$0.1150
$0.115+0.005+4.5%$0.115$0.115$0.1154,500
$0.1100.0000.0%$0.110$0.110$0.1100
$0.1100.0000.0%$0.110$0.110$0.1100
$0.1100.0000.0%$0.110$0.110$0.1100
$0.1100.0000.0%$0.110$0.110$0.1100
$0.1100.0000.0%$0.110$0.110$0.1100
$0.1100.0000.0%$0.110$0.110$0.1101,522
$0.1100.0000.0%$0.140$0.140$0.1103,000
$0.110+0.010+10.0%$0.110$0.110$0.1101,121
$0.1000.0000.0%$0.100$0.100$0.1000
$0.1000.0000.0%$0.100$0.100$0.1000
$0.1000.0000.0%$0.100$0.100$0.1000
$0.1000.0000.0%$0.100$0.100$0.1000
$0.100-0.030-23.1%$0.130$0.130$0.10014,888
$0.1300.0000.0%$0.130$0.130$0.1300
$0.1300.0000.0%$0.130$0.130$0.130500
$0.1300.0000.0%$0.130$0.130$0.1301,000
$0.130-0.015-10.3%$0.140$0.140$0.13016,000
$0.1450.0000.0%$0.145$0.145$0.1450
$0.1450.0000.0%$0.145$0.145$0.1450
$0.1450.0000.0%$0.145$0.145$0.145800
$0.1450.0000.0%$0.145$0.145$0.1450
$0.1450.0000.0%$0.145$0.145$0.1450
$0.1450.0000.0%$0.145$0.145$0.1450
$0.1450.0000.0%$0.145$0.145$0.1453,000
$0.1450.0000.0%$0.145$0.145$0.1450
$0.1450.0000.0%$0.145$0.145$0.1450
$0.1450.0000.0%$0.145$0.145$0.145500
$0.1450.0000.0%$0.145$0.145$0.1453,000
$0.1450.0000.0%$0.145$0.145$0.1450
$0.1450.0000.0%$0.145$0.145$0.145500
$0.1450.0000.0%$0.145$0.145$0.1450
$0.1450.0000.0%$0.145$0.145$0.1450
$0.1450.0000.0%$0.145$0.145$0.1450
$0.1450.0000.0%$0.145$0.145$0.1450
$0.1450.0000.0%$0.145$0.145$0.1450
$0.1450.0000.0%$0.145$0.145$0.1450
$0.1450.0000.0%$0.145$0.145$0.1450
$0.1450.0000.0%$0.145$0.145$0.1450
$0.1450.0000.0%$0.145$0.145$0.1450
$0.1450.0000.0%$0.145$0.145$0.1450
$0.1450.0000.0%$0.145$0.145$0.145500
$0.1450.0000.0%$0.145$0.145$0.1450
$0.145-0.005-3.3%$0.150$0.150$0.1453,000
$0.1500.0000.0%$0.150$0.150$0.150504
$0.1500.0000.0%$0.150$0.150$0.150500
$0.150-0.010-6.3%$0.150$0.150$0.1503,500
$0.1600.0000.0%$0.160$0.160$0.1600
$0.160-0.010-5.9%$0.160$0.160$0.16020,610
$0.170-0.005-2.9%$0.170$0.170$0.1702,000
$0.1750.0000.0%$0.175$0.175$0.1750
$0.1750.0000.0%$0.175$0.175$0.1750
$0.1750.0000.0%$0.175$0.175$0.1750
$0.175+0.015+9.4%$0.180$0.180$0.17512,110
$0.1600.0000.0%$0.160$0.160$0.1600
$0.1600.0000.0%$0.160$0.160$0.1600
$0.1600.0000.0%$0.160$0.160$0.1604,040
$0.1600.0000.0%$0.160$0.160$0.1600
$0.1600.0000.0%$0.160$0.160$0.1600
$0.1600.0000.0%$0.160$0.160$0.1600
$0.1600.0000.0%$0.160$0.160$0.1600
$0.1600.0000.0%$0.160$0.160$0.1600

Splits

3 splits since 2012 · TSXV:VXL · every price before a split is adjusted for it

DayRatioWhat
1-for-50Consolidation
1-for-7Consolidation
1-for-2Consolidation
Ticker
TSXV:VXL
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
TSXV
Currency
CAD

What changed lately

Latest news

All Vaxil Bio Ltd. news

Vaxil Bio Ltd. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
2 in the last 12 months · 25 in all · newest Dec 4, 2025 · oldest 2005
Decks
2 decks · latest January 2021

Where Vaxil Bio Ltd. is listed

ListingExchangeCountryCurrency
TSXV:VXL · Home listing · This pageTSXVCanadaCAD
OTC:VXLLFOTCUnited StatesUSD
Cboe Canada:VXLCboe CanadaCanadaCAD

Valuation

Price/book 0.4× against a median of 0.1×: the highest of 6 Biotechnology companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 19, 2026

Enterprise value
−$5,838 CAD
P/E
1.2×
EV/sales
No revenue
EV/EBITDA
No depreciation figure on 6ix yet
Price/book
0.4×
Gross margin
No revenue
Operating margin
No revenue
Net margin
No revenue
Debt to equity
0.0×
Beta vs S&P/TSX Composite
-0.16

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Vaxil Bio Ltd. · TSXV:VXLUS$319,477−US$4,0711.2×n/an/a0.4×n/a0.0×-0.16
Lakewood-Amedex Biotherapeutics Inc. · NASDAQ:LABTUS$580,337−US$2.74Mn/an/an/a0.2×n/a0.0×0.46
Mushrooms, Inc. · OTC:MSRMUS$539,339US$564,177n/an/an/an/an/an/a1.24
Jaguar Health, Inc. · NASDAQ:JAGXUS$527,406−US$1.48Mn/a−0.1×n/a0.0×−181.8%0.2×3.75
Altamira Therapeutics Ltd. · OTC:CYTOFUS$404,655US$400,900n/an/an/a0.1×n/a0.0×0.64
NKGen Biotech Inc. · OTC:NKGNUS$391,807US$38.58Mn/an/an/an/an/an/a0.88
Chimeric Therapeutics Limited · ASX:CHMUS$292,816−US$220,193n/a−0.1×n/a0.2×−262.8%2.5×n/a
CERo Therapeutics Holdings, Inc. · OTC:CEROUS$265,035−US$190,890n/an/an/an/an/an/a1.47
CDT Equity Inc. · NASDAQ:CDTUS$234,109−US$1.49Mn/an/an/a0.0×n/a0.0×1.14
GlucoTrack, Inc. · NASDAQ:GCTKUS$217,049−US$887,951n/an/an/an/an/an/a1.73
Regen BioPharma, Inc. · OTC:RGBPUS$167,528US$167,289n/a0.7×n/an/a−501.4%n/a1.20
Median of the othersUS$342,312−US$205,542−0.1×0.1×−262.8%0.0×1.20

Team and board

OfficerRole
Gadi LevinCEO

Events

Next results
Nov 26, 2026 (expected)

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (January 2021)Investor deck15 slidesJanuary 2021
Investor Presentation (October 2020)Investor deck15 slidesOctober 2020

Open Decks

Financings

RaiseDateIn US dollars
Private placement of units
Closed: C$140,000 raised · C$0.1125 a unit · 1 warrant at C$0.15 for 60 months · free to trade Apr 3, 2026
Use of proceeds: To continue exploring strategic options beyond the health care sector to maximize shareholder value
Dec 4, 2025US$100,344

Open Financings · Read by 6ix AI from the company's releases

Financials

Annual, in CAD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue0000000000
Cost of revenue2.00K25.0K57.0K100.0K56.0K47.0K22.0K
Gross profit-2.00K-25.0K-57.0K-100.0K-56.0K-47.0K-22.0K
Research and development12.0K114343.0K539.0K619.0K750.0K575.0K838.0K585.0K
Selling, general and administrative179.0K148.0K120239.0K428.0K724.0K383.0K466.0K965.0K3.90M
Operating income-179.0K-148.0K-254-584.0K-986.0K-1.35M-1.14M-1.04M-1.80M-4.55M
Depreciation and amortization02.00K25.0K57.0K100.0K56.0K47.0K22.0K
EBITDA-254-582.0K-961.0K-1.29M-1.04M-985.0K-1.76M-4.53M
Interest expense4.00K11.0K11.0K05.00K10.0K
Income before tax521.0K-130.0K-254-584.0K-986.0K-1.36M-1.15M-1.05M-1.80M-4.54M
Income tax11.0K11.0K6.00K-5.00K100.0K
Net income522.0K-178.0K-254-584.0K-986.0K-1.37M-1.17M-1.05M-1.80M-4.54M
Earnings per share, basic0.13-0.06-0.00-0.00-0.01-0.01-0.01-0.01-0.04-0.12

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents671.0K448.0K938.0K1.51M2.24M1.51M83.0K753.0K169.0K1.02M
Receivables19.0K20.0K35.0K33.0K11.0K57.0K13.0K26.0K
Inventory19.0K
Current assets685.0K733.0K976.0K1.54M2.28M1.63M110.0K828.0K192.0K1.05M
Property, plant and equipment2.00K27.0K95.0K62.0K118.0K165.0K
Total assets1.37M733.0K976.0K1.54M2.29M1.66M205.0K890.0K310.0K1.22M
Accounts payable85394559588.0K618.0K335.0K438.0K370.0K
Current liabilities5.00K17.0K85.0K405.0K585.0K857.0K777.0K455.0K748.0K477.0K
Total debt9.00K17.0K5.00K78.0K17.0K
Total liabilities5.00K17.0K85.0K405.0K585.0K857.0K788.0K455.0K797.0K561.0K
Shareholders' equity1.36M716.0K891.0K1.14M1.70M804.0K-583.0K435.0K-487.0K656.0K
Shares outstanding3.98M2.74M137.0M137.0M136.1M101.7M88.9M85.1M50.4M39.4M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-158.0K-188.0K-561.0K-734.0K-1.08M-1.10M-596.0K-943.0K-1.00M-1.50M
Capital spending000000000-164.0K
Free cash flow-158.0K-188.0K-561.0K-734.0K-1.08M-1.10M-596.0K-943.0K-1.00M-1.33M
Cash from investing165.0K
Cash from financing127.0K035.0K1.81M2.56M-68.0K1.52M115.0K2.33M
Share buybacks150.0K2.33M
Change in cash223.0K-490.0K-572.0K-731.0K731.0K1.43M-670.0K584.0K-854.0K1.01M

Open Financials

Cap table

Built by 6ix from Vaxil Bio Ltd.’s releases · as of Dec 4, 2025

Common shares
3,984,020
Fully diluted
5,228,461

Fully diluted

LineSharesAs of
Common shares3,984,020
Warrants1,244,441Dec 4, 2025

Warrants and options

Lot
Warrants · C$0.15 · expire about Dec 2030

Share count over time

CountShares
Nov 22, 20263,984,020

Open Cap table

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Gadi LevinCEO · Since at least Dec 4, 2025

Open People

Log in to ask 6ix AI your own questions about Vaxil Bio Ltd.